Cargando…
Performance of 30 commercial SARS-CoV-2 serology assays in testing symptomatic COVID-19 patients
We report evaluation of 30 assays’ (17 rapid tests (RDTs) and 13 automated/manual ELISA/CLIA assay (IAs)) clinical performances with 2594 sera collected from symptomatic patients with positive SARS-CoV-2 rRT-PCR on a respiratory sample, and 1996 pre-epidemic serum samples expected to be negative. On...
Ejemplares similares
-
Comparison between enzyme‐linked immunospot assay and intracellular cytokine flow cytometry assays for the evaluation of T cell response to SARS‐CoV‐2 after symptomatic COVID‐19
por: Villemonteix, Juliette, et al.
Publicado: (2022) -
Infectious Zika virus in vaginal secretions from an HIV-infected woman, France, August 2016
por: Penot, Pauline, et al.
Publicado: (2017) -
Variable In Vivo Hepatitis D Virus (HDV) RNA Editing Rates According to the HDV Genotype
por: Dziri, Samira, et al.
Publicado: (2021) -
The Coris BioConcept COVID 19 Ag Respi-Strip, a field experience feedback
por: Mizrahi, Assaf, et al.
Publicado: (2022) -
Comprehensive Analysis of Hepatitis Delta Virus Assembly Determinants According to Genotypes: Lessons From a Study of 526 Hepatitis Delta Virus Clinical Strains
por: Gerber, Athenaïs, et al.
Publicado: (2021)